SCHEMBL681580

SCHEMBL681580

C=C(C(C)C)[C@H](CNC(C)C)c1ccc(C(F)(F)F)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
PDE2A O00408 13/20 0.39
FFAR1 O14842 1/20 0.37
AKT1 P31749 2/20 0.37
RPS6KB1 P23443 1/20 0.37
TRPV1 Q8NER1 2/20 0.36
PDE6D O43924 1/20 0.36
PDE5A O76074 1/20 0.36
PDE6A P16499 1/20 0.36
PDE6G P18545 1/20 0.36
PDE4A P27815 1/20 0.36
PDE6B P35913 1/20 0.36
PDE6C P51160 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PDE6H Q13956 1/20 0.36
PDE11A Q9HCR9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL681710 0.90 AKT1 (0.45) ADRB2ADRB1ADRB3AKT1RPS6KB1
SCHEMBL680749 0.87 PDE2A (0.41) ADRB2ADRB1ADRB3PDE2AFFAR1
SCHEMBL683420 0.86 AKR1C3 (0.42) ADRB2ADRB1ADRB3PDE2AFFAR1
SCHEMBL680064 0.85 PDPK1 (0.44) ADRB2ADRB1ADRB3
SCHEMBL2738399 0.85 AKT1 (0.43) ADRB2ADRB1ADRB3PDE2AFFAR1
SCHEMBL681158 0.84 AKT1 (0.46) AKT1RPS6KB1AKR1C3AKR1C2
SCHEMBL17803796 0.83 ADRB2 (0.41) ADRB2ADRB1ADRB3AKR1C3AKR1C2
SCHEMBL680149 0.82 AKT1 (0.49) PDE2AAKT1
SCHEMBL681191 0.82 AKT1 (0.44) ADRB2ADRB1ADRB3FFAR1AKT1
SCHEMBL680197 0.82 ADRB2 (0.40) ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063050-B2 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors ARRAY BIOPHARMA INC. (US) 2011-11-22 US disclosed